S.08.06 MDMA-assisted psychotherapy for PTSD: A promising novel experimental treatment moving into phase 3 trials with FDA breakthrough therapy designation.

Saved in:
Bibliographic Details
Title: S.08.06 MDMA-assisted psychotherapy for PTSD: A promising novel experimental treatment moving into phase 3 trials with FDA breakthrough therapy designation.
Authors: Mithoefer, M.1, Mithoefer, A.2, Feduccia, A.3, Jerome, I.4, Wagner, M.5, Hoilland, J.6, Hamilton, S.7, Yazar-Klosinski, B.8, Emerson, A.9, Doblin, R.10
Source: European Neuropsychopharmacology. 2019 Supplement1, Vol. 29, pS11-S12. 2p.
Database: Academic Search Ultimate
Description
ISSN:0924977X
DOI:10.1016/j.euroneuro.2018.11.930